Fetal hemoglobin in sickle cell anemia: Relation to regulatory sequences cis to the β-globin gene

Blood

Volumn 87, Issue 4, 1996, Pages 1604-1611

  Lu, Zhi Hong ^a   Steinberg, Martin H ^a,b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; GAMMA GLOBIN; HEMOGLOBIN BETA CHAIN; HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; HEMOGLOBIN S;

ARTICLE; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC TRANSCRIPTION; GLOBIN GENE; HAPLOTYPE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SICKLE CELL ANEMIA;

EID: 0030062162     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1604.bloodjournal8741604     Document Type: Article

References (41)

1. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR: Pain in sickle cell disease-rates and risk factors. N Engl J Med 325:11, 1991
2. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 330:1639, 1994
3. Steinberg MH, Hsu H, Nagel RL, Milner PF, Adams JG, Benjamin L, Fryd S, Gillette P, Gilman J, Josifovska O, Hellman-Erlingsson S, Safaya S, Huey L, Rieder RF: Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol 48:175, 1995
4. Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW: Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 322:1037, 1990
5. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, Multicenter Study Hydroxyurea: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317, 1995
6. Dover GJ, Smith KD, Chang YC, Purvis S, Mays A, Meyers DA, Sheils C, Serjeant G: Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 80:816, 1992
7. Thein SL, Sampietro M, Rohde K, Rochette J, Weatherall DJ, Lathrop GM, Demenais F: Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. Am J Hum Genet 54:214, 1994
8. Nagel RL, Fabry ME, Pagnier J, Zohoun I, Wajcman H, Baudin V, Labie D: Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med 312:880, 1984
9. Gγ globin production. Blood 66:783, 1985
10. Blau CA, Stamatoyannopoulos G: Regulation of fetal hemoglobin, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice, New York, NY, Raven, 1994, p 247
11. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3:2303, 1976
12. Dozy AM, Kan YW, Embury SH, Mentzer WC, Wang WC, Lubin B, Davis JR Jr, Koenig HM: α-Globin gene organisation in blacks precludes the severe form of α-thalassaemia. Nature 280:605, 1979
13. Chehab FF, Doherty M, Cai S, Kan YW, Cooper S, Rubin EM: Detection of sickle cell anaemia and thalassaemias. Nature 329:293, 1987
14. Betke K, Marti HR, Schlicht I: Estimation of small percentages of foetal haemoglobin. Nature 184:1887, 1959
15. Saiki RK, Gelfand DH, Stoffel S, Sharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487, 1988
16. Coleman MB, Steinberg MH, Adams JG, III: Hemoglobin Terre Haute arginine β106. A posthumous correction to the original structure of hemoglobin Indianapolis. J Biol Chem 266:5798, 1991
17. Innis MA, Myambo KB, Gelfand DH, Brow MAD: DNA sequencing with Thermis aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. Proc Natl Acad Sci USA 85:9436, 1988
18. Fucharoen S, Fucharoen G, Ata K, Aziz S, Hashim S, Hassan K, Fukumaki Y: Molecular characterization and nonradioactive detection of beta-thalassemia in Malaysia. Acta Haematol (Basel) 84:82, 1990
19. A chromosome of sickle cell traits. Am J Hematol 43:312, 1993
20. Gγ gene in cis. Am J Hematol 47:307, 1994
21. Orkin SH, Kazazian HH Jr, Antonarakis SE, Goff SC, Boehm CD, Sexton JP, Waber PG, Giardina PJ: Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296:627, 1982
22. Antonarakis SE, Boehm CD, Giardina PV, Kazazian HH: Nonrandom association of polymorphic restriction sites in the β-globin gene cluster. Proc Natl Acad Sci USA 79:137, 1982
23. Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, Labie D: Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci USA 81:1771, 1984
24. S chromosomes are specific for chromosomes with major haplotypes. Acta Haematol (Basel) 85:79, 1991
25. S chromosomes with five different haplotypes. Blood 77:2488, 1991
26. S chromosomes are associated with different levels of fetal globin in hemoglobin S homozygotes. Blood 79:813, 1992
27. Périchon B, Ragusa A, Lapouméroulie C, Romand A, Moi P, Ikuta T, Labie D, Elion J, Krishnamoorthy R: Inter-ethnic polymorphism of the β-globin gene locus control region (LCR) in sickle-cell anemia patients. Hum Genet 91:464, 1993
28. Pissard S, Beuzard Y: A potential regulatory region for the expression of fetal hemoglobin in sickle cell disease. Blood 84:331, 1994
29. S mutation. Blood 79:787, 1992
30. Townes TM, Behringer RR: Human globin locus activation region (LAR): Role in temporal control. Trends Genet 6:219, 1990
31. Caterina JJ, Ryan TM, Pawlik KM, Palmiter RD, Brinster RL, Behringer RR, Townes TM: Human β-globin locus control region: Analysis of the 5′ DNase I hypersensitive site HS 2 in transgenic mice. Proc Natl Acad Sci USA 88:1626, 1991
32. Grosveld F, Antoniou M, Berry M, De Boer E, Dillon N, Ellis J, Fraser P, Hanscombe O, Hurst J, Imam A, Lindenbaum M, Philipsen S, Pruzina S, Strouboulis J, Raguz-Bolognesi S, Talbot D: The regulation of human globin gene switching. Phil Trans R Soc Lond [Biol] 339:183, 1993
33. Strauss EC, Orkin SH: In vivo protein-DNA interactions at hypersensitive site 3 of the human β-globin locus control region. Proc Natl Acad Sci USA 89:5809, 1992
34. Pruzina S, Hanscombe O, Whyatt D, Grosveld F, Philipsen S: Hypersensitive site 4 of the human β globin locus control region. Nucleic Acids Res 19:1413, 1991
35. S chromosomes. Hemoglobin 17:475, 1993
36. Berg PE, Mittelman M, Elion J, Labie D, Schechter AN: Increased protein binding to a -530 mutation of the human β-globin gene associated with decreased β-globin synthesis. Am J Hematol 36:42, 1991
37. Miyoshi K, Kaneto Y, Kawai H, Ohchi H, Niki S, Hasegawa K, Shirakami A, Yamano T: X-linked dominant control of F-cells in normal adult life: Characterization of the Swiss type as hereditary persistence of fetal hemoglobin regulated dominantly by gene(s) on X chromosome. Blood 72:1854, 1988
38. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ: An analysis of fetal hemoglobin variation in sickle cell disease: The relative contributions of the X-linked factor, β-globin haplotypes, α-globin gene number, gender, and age. Blood 85:1111, 1995
39. Stamatoyannopoulos G, Nienhuis AW: Hemoglobin switching, in Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds): The Molecular Basis of Blood Diseases. Philadelphia, PA, Saunders, 1994, p 107
40. Li Q, Stamatoyannopoulos JA: Position independence and proper developmental control of gamma-globin gene expression require both a 5′ locus control region and a downstream sequence element. Mol Cell Biol 14:6087, 1994
41. Aγ-globin gene functions in conjuction with an upstream LCR to mediate position-independent γ-globin gene expression. Blood 84:218a, 1994 (abstr, suppl 1)